瞬时弹性检测技术在肝脏疾病诊断中的应用

doi:10.3969/j.issn.1672-5069.2016.01.031

Abstract

Song Le, Jiang Xiaojing. Application of transient elastography in diagnosis of liver fibrosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(1): 105-108.

[1] 黄燕平,郑永平. 基于超声的组织弹性测量之剪切波传播法. 中国医疗设备,2011,26（10）：1–12.
[2] 沈洋,凌涛,姚惠,等. 超声瞬时弹性成像算法与系统设计. 集成技术,2012,1（1）：94–99.
[3] 田丽艳,陆伦根. 肝纤维化影像学诊断研究进展. 国际消化病杂志,2013,33（5）：292-294.
[4] Sandrin L,Fourquet B. Transient elastography：a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol,2003,29（12）：1705–1713.
[5] 郑永平,黄燕平. 生物组织弹性测量：技术、仪器和应用. 中国医疗设备,2011,26（5）：1-15.
[6] 李文庭,高人焘. Fibroscan临床应用进展.国际流行病学传染病学杂志,2012,39（5）：344–348.
[7] Sandrin L,Fourquet B,Hasquenoph JM,et al. Transient elastography：a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol,2003,29（12）：1705–1713.
[8] Fraquelli M,Rigamonti C,Casazza G,et a1.Etiology–related determinants of liver stiffness values in chronic viral hepatitis B or C.J Hepatol,2011,54（4）：621–628.
[9] 李冰,纪冬,牛小霞,等. Fibroscan对原发性胆汁性肝硬化患者肝纤维化的诊断价值. 肝脏,2014,19（8）：585–587.
[10] 戴维佳,阮隽,汤伟亮,等. 肝脏瞬时弹性超声在药物性肝损伤患者肝纤维化诊断中的作用. 中华传染病杂志,2013,31（9）：529–532.
[11] 沈峰,范建高. 瞬时弹性成像技术在脂肪性肝病中的应用现状.中华肝脏病杂志,2014,22（9）：643–646.
[12] Pathik P,Ravindra S,Ajay C,et al. Fibroscan versus simple noninvasive screening tools in predicting fibrosis in high–risk nonalcoholic fatty liver disease patients from Western India. Ann Gastroenterol,2015,28（2）：281–286.
[13] Grace LH Wong. Prediction of fibrosis progression in chronic viral hepatitis. Clin Mol Hepatol,2014,20（3）：228–236.
[14] Ikeda K,Saitoh S,Suzuki Y,et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis：a prospective observation of 2215 patients. J Hepatol,1998,28（6）：930–938.
[15] 陈永鹏,梁携儿,张琪,等. 瞬时弹性扫描检测慢性乙型肝炎病情严重程度的研究. 中华内科杂志,2011,50（9）：758–762.
[16] 谢建亮,旭鹏,杨嘹嘹. 瞬时弹性扫描检测乙型肝炎后肝硬化病情严重程度的研究. 中国基层医药,2013,20（13）：2001–2002.
[17] Corpechot C,Carrat F,Poujol–Robert A,et al. Noninvasive elastography–based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis.Hepatology,2012,56（1）：198–208.
[18] 陈国凤.瞬时弹性成像的研究进展及临床应用. 解放军医学杂志,201l,36（2）：1131–1133.
[19] Wong GK,Chan HL,Wong CK,et al.Liver stiffness–based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.J Hepatol,2014,60（2）：339–345.
[20] Hu Z,Li Y,Li C,et al. Using ultrasonic transient elastometry （FibroScan） to predict esophageal varices in patients with viral liver cirrhosis. Ultrasound Med Biol,2015,41（6）：1530–1537.
[21] 李梵,闫涛,邵清. 肝硬化患者食管静脉曲张程度无创诊断的临床研究. 中华肝脏病杂志,2014,22（8）：600–603.
[22] 李庭红,刘芳,韩涛. 脾脏硬度对肝硬化患者食管胃底静脉曲张的评估. 中华传染病杂志,2012,30（10）：603–608.
[23] Berzigotti A,Bosch J,Boyer TD. Use of noninvasive markers of portal hypertension and timing of screening endoscopy for gastroesophageal varices in patients with chronic liver disease.Hepatology,2014,59（2）：729–731.
[24] Bota S,Sporea I,Sirli R,et al. Can ARFI elastography predict the presence of significant esophageal varices in newly diagnosed cirrhotic patients. Ann Hepatol,2012,11（4）：519–525.
[25] 唐文博,焦子育,穆晨.内镜下食管胃底静脉曲张治疗对肝硬化患者肝脏及弹性指数的影响.中国医学影像学杂志,2013,21（5）：374–376.
[26] 郭风彩,濮翔科,龚菁. 瞬时弹性扫描仪在评价恩替卡韦治疗乙型肝炎代偿期肝硬化患者中的作用.中华传染病杂志,2012,30（9）：555–557.
[27] Patel K,Friedrich–Rust M,Lurie Y, et al. FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus. World J Gastroenterol,2011,17（41）：4581–4589.
[28] 袁成民,孙庆勇,杨铂,等. 瞬时肝弹性测定评价芪冬复肝合剂的抗肝纤维化作用. 中国中医药科技,2013,20（5）：455–466.
[29] 王玉忠. Fibroscan验证鳖甲软肝片抗纤维化临床观察.山西中医,2013,29（6）：15–17.
[30] 丁元,刘建华,严盛,等. 应用瞬时弹性成像技术预测肝移植早期预后. 中华器官移植杂志,2014,35（6）：346–349.
[31] 武荣,罗渝昆,吕发勤,等. 剪切波弹性成像技术评价肝创伤执行治疗预后的动物实验研究.中华医学超声杂志,2011,8（9）：1914–1921.
[32] 赵夏夏,吴永胜,苗英,等. 不同年龄段人群正常肝脏弹性成像定量的相关性分析. 西北国防医学杂,2012,33（5）：539–541.
[33] 刘志权,冯军花,叶立红,等. 肝组织炎症对瞬时弹性成像技术诊断慢性乙型肝炎肝纤维化分期的影响.实用医学杂志,2013,29（3）：401–403.
[34] Zeng X,Xu C,He D,et al. Influence of hepatic inflammation on FibroScan findings in diagnosing fibrosis in patients with chronic hepatitis B. Ultrasound Med Biol,2015,41（6）：1538–1544.
[35] Arena U,Lupsor Platon M,Stasi C,et al. Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution.Hepatology,2013,58（1）：65–72.
[36] 夏长虹,王伟芳,曹建彪,等.进食对肝脏瞬时弹性检测仪检测肝脏硬度值的影响.北京医学,2014,36（6）：462–464.
[37] 张植兰,朱才义. 实时剪切波弹性成像技术在肝脏中的应用现状.中华医学超声杂志,2014,11（2）：108–110.
[38] Castera L,Foucher J,Bermard PH,et a1.Pitfalls of liver stiffness measurement：a 5–year prospective study of 1 3,369 examinations.Hepatology,2010,51（3）：828–835.
[39] Myers RP,Pomier I,Kirsch R,et a1. Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe. J Hepatol,2012,56（3）：564–570.
[40] You SC,Kim KJ,Kim SU,etal. Factors associated with significant liver fibrosis assessed using transient elastography in general population. World J Gastroenterol,2015,21（4）：1158–1166.
[41] 马科,丁红方,宁琴,等. Fibroscan检测肝纤维化影响因素的研究进展. 肝脏,2010,15（3）：204–206.
[42] Aalaei–Andabili SH,Mehrnoush L,Salimi S,et al. Liver Hemangioma might lead to overestimation of liver fibrosis by Fibroscan：A missed issue in two Cases. Hepat Mon,2012,12（6）：408–410.
[43] 李冰,张健,陈国凤,等. Fibroscan临床应用新进展. 传染病信息,2013,26（3）：186–189.
[44] Pradhan F,Ladak F,Tracey J,et al. Feasibility and reliability of the FibroScan S2 （pediatric） probe compared with the M probe for liver stiffness measurement in small adults with chronic liver disease. Ann Hepatol,2013,12（1）：100–107.
[45] 黄燕平,郑永平. 基于超声的组织弹性测量之剪切波传播法. 中国医疗设备,2011,26（10）：1–12.
[46] 周家玲,魏巍,尤红. 肝纤维化无创技术的临床研究及进展. 临床肝胆病杂志,2014,30（7）：604–607.

Application of transient elastography in diagnosis of liver fibrosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[2]	. Consensus on the diagnosis and therapy of hepatic fibrosis [J]. Journal of Practical Hepatology, 2019, 22(6): 793-803.
[3]	chronic hepatitis B virus carriers Wu Haiyi, Chen Jianxin.. Diagnostic efficacy of four non-invasive diagnostic models in evaluating significant liver fibrosis in [J]. Journal of Practical Hepatology, 2019, 22(6): 832-835.
[4]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[5]	Zeng Yanni, Zhang Can, Bi Junying, et al.. Value of long-time delayed enhancement scan of MRI in the diagnosis of solitary necrotic nodule of liver [J]. Journal of Practical Hepatology, 2019, 22(6): 900-903.
[6]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[7]	Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943.
[8]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[9]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[10]	Hong Jia, Wu Xiaoning, You Hong. Standardized diagnosis of cholestatic liver diseases [J]. Journal of Practical Hepatology, 2019, 22(5): 758-760.
[11]	Cheng Hua, Ju Hui, Song Deshun et al. Value of serum angiopoietin-like protein 2 and Golgi protein 73 levels in the diagnosis of hepatic fibrosis in patient with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 494-497.
[12]	Yu Yingfang, Wen Shengbao. Assessment of liver fibrosis with diffusion-weighted magnetic resonance imaging using single, double and stretch index model in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 502-505.
[13]	Zhang Yafei, Ye Jun, Xie Qinxiu, et al. Difference in predicting efficacy of significant liver fibrosis by noninvasive liver fibrosis index in different hospitals [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 510-513.
[14]	Xie Xiao, Liu Ting, Dong Zhixia, et al. Value of controlled attenuation parameter in diagnosis of individuals with liver steatosis by using Fibrotouch [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 526-529.
[15]	Zhang Junfei, Xu Heming, Song Haiyan, et al. Autoimmune hepatitis-primary biliary cholangitis overlap syndrome:poor diagnostic sensitivity of Paris' criteria in Chinese patients [J]. Journal of Practical Hepatology, 2019, 22(4): 537-540.